MALACHITE INNOVATIONS ANNOUNCES FORMER NFL QUARTERBACK BERNIE KOSAR HAS JOINED THE COMPANY AS A STRATEGIC ADVISOR

CLEVELAND, OHIO – (December 21, 2022) – MALACHITE INNOVATIONS, INC. (OTC...

read more
MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON MITIGATION BANKING TO RESTORE ENVIRONMENTALLY DEGRADED STREAMS AND WETLANDS

CLEVELAND, OHIO – (December 20, 2022) – MALACHITE INNOVATIONS, INC. (OTC...

read more
MALACHITE INNOVATIONS LAUNCHES TERRA PRETA, A NEW BUSINESS FOCUSED ON PRODUCING BIOCHAR FOR AGRICULTURAL AND WATER FILTRATION MARKETS

CLEVELAND, OHIO – (December 15, 2022) – MALACHITE INNOVATIONS, INC. (OTC...

read more
MALACHITE INNOVATIONS ANNOUNCES EXPANSION OF SENIOR LEADERSHIP TEAM AND ENGAGEMENT OF TWO NEW STRATEGIC ADVISORS

CLEVELAND, OHIO – (December 1, 2022) – MALACHITE INNOVATIONS, INC. (OTC...

read more
MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON PROVIDING ECO-FRIENDLY, TECHNOLOGY-DRIVEN SECURITY SERVICES TO ACTIVE AND FORMER MINE SITES USING MILITARY VETERANS AND FIRST RESPONDERS

CLEVELAND, OHIO – (November 29, 2022) – MALACHITE INNOVATIONS, INC. (OTC...

read more
MALACHITE INNOVATIONS ANNOUNCES CLOSING OF $3.0 MILLION CAPITAL RAISE AND INITIAL ESG ACQUISITIONS

CLEVELAND, OHIO – (May 13, 2022) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...

read more
MALACHITE INNOVATIONS ANNOUNCES SIGNED LETTER OF INTENT WITH RANGE
ENVIRONMENTAL RESOURCES, INC.

CLEVELAND, OHIO – (March 15, 2022) – MALACHITE INNOVATIONS, INC. (OTC Mkts:...

read more
MALACHITE INNOVATIONS ANNOUNCES TWO GRANTED U.S. PATENTS AND NEW PCT PATENT FILING

CLEVELAND, OHIO – (December 28, 2021) – MALACHITE INNOVATIONS, INC. (OTC...

read more
VITALITY BIOPHARMA ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC.

New Corporate Name Reflects Company’s Expanded Business Strategy, Corporate...

read more
VITALITY BIOPHARMA ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY

CLEVELAND, OHIO – (September 2, 2021) – Vitality Biopharma, Inc. (OTC Mkts:...

read more
VITALITY BIOPHARMA ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP WITH INSTITUTIONAL INVESTOR

CLEVELAND, OHIO – (August 20, 2021) – Vitality Biopharma, Inc. (VBIO)...

read more
FDA GRANTS VITALITY BIOPHARMA ORPHAN DRUG DESIGNATION FOR VBX-100 PRODRUG

CLEVELAND, OHIO – (August 10, 2021) – Vitality Biopharma, Inc. (VBIO)...

read more
CEO LETTER TO SHAREHOLDERS

To the Shareholders of Vitality Biopharma, Inc.: In October 2018, Vitality...

read more
VITALITY BIOPHARMA RETAINS DELMORGAN & CO. TO EXPLORE STRATEGIC ALTERNATIVES

CLEVELAND, OHIO – (September 25, 2020) – Vitality Biopharma, Inc. (OTCQB:...

read more
VITALITY BIOPHARMA BOARD UPDATE

CLEVELAND, OHIO – (April 27, 2020) — Vitality Biopharma, Inc. (Ticker:...

read more
VITALITY BIOPHARMA WELCOMES NEW EXECUTIVE MANAGEMENT TEAM

– Appointment of Current Director Michael Cavanaugh as Interim Chief...

read more
VITALITY BIOPHARMA CO-FOUNDER DR. AVTAR DHILLON RESIGNS FROM BOARD OF DIRECTORS

LOS ANGELES, CA – (April 25, 2019) — Vitality Biopharma, Inc. (Ticker:...

read more
VITALITY BIOPHARMA APPOINTS FORMER OHIO GOVERNOR RICHARD F. CELESTE TO BOARD

LOS ANGELES, Jan. 24, 2019 — Vitality Biopharma, Inc. (Ticker: VBIO)...

read more
VITALITY BIOPHARMA ANNOUNCES CORPORATE UPDATES AND COMPLETION OF AN SEC EXAMINATION

Company appoints two new directors including the Hon. Edward Feighan as new...

read more

Website Design by 71Three